The meeting provided a spectrum of practice-changing studies, early-stage data for novel therapies, and advances in notable trends such as immuno-oncology and cellular therapy. The Axiom Healthcare Strategies team attended the meeting to understand and discuss the data presented with thought leaders, and here we summarize our key takeaways.
Commentaires